- Home
- PWP vs ABSI Comparison
PWP vs ABSI Comparison
Compare PWP & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PWP | ABSI |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 997.8M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PWP | ABSI |
|---|---|---|
| Price | $15.65 | $7.32 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $23.50 | $6.96 |
| AVG Volume (30 Days) | 1.3M | ★ 4.8M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.31% | N/A |
| EPS Growth | ★ 138.52 | 10.64 |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | $28.86 | $215.96 |
| Revenue Next Year | $18.95 | $319.10 |
| P/E Ratio | $791.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.54 | $2.24 |
| 52 Week High | $25.93 | $8.17 |
Technical Indicators
Market Signals| Indicator | PWP | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 41.29 | 63.71 |
| Support Level | $15.74 | $2.55 |
| Resistance Level | $19.09 | N/A |
| Average True Range (ATR) | 0.85 | 0.71 |
| MACD | 0.13 | 0.03 |
| Stochastic Oscillator | 45.25 | 70.67 |
Price Performance
Historical ComparisonAbout PWP Perella Weinberg Partners
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.